<DOC>
	<DOC>NCT02708771</DOC>
	<brief_summary>Assess whether high doses of ?-3 fatty acids added to standard treatment of patients with acute hearta failure, hypoalbuminemia and high inflammatory activity, promotes an increase in serum albumin</brief_summary>
	<brief_title>Effect of W-3 Polyunsaturated Fatty Acids on Serum Albumin Concentration in Patients With Acute Heart Failure, Hypoalbuminemia, and High Inflammatory Activity</brief_title>
	<detailed_description>Assess whether high doses of ?-3 fatty acids added to standard treatment of patients with acute hearta failure, hypoalbuminemia and high inflammatory activity, promotes an increase in serum albumin Assess the effect of high doses of ?-3 fatty acids added to standard treatment of patients with acute hearta failure, hypoalbuminemia and high inflammatory activity on: - Inflammatory activity (C-reactive protein) - The development of biomarkers (NTproBNP). - The prognosis of patients evaluated by the combined event of death from any cause or readmission for heart failure within three months after randomization.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hypoalbuminemia</mesh_term>
	<mesh_term>Eicosapentaenoic acid ethyl ester</mesh_term>
	<criteria>Patients aged 18 years or olders hospitalized for acute heart failure, chronic decompensated or new onset of any etiology, presenting hypoalbuminemia (serum albumin ?3,4 g / dl) and high inflammatory activity (CRP ?2,5 mg / dl). Impending doom Participating in other clinical trials Treatment with ?3 acids in the last month prior to admission Percutaneous or surgical treatment of the cause of heart failure during hospitalization. Pregnant women. Renal failure on dialysis. Chronic liver disease ChildPugh B or C. Acute infectious process. Active malignant neoplasia.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>